A detailed history of Coastline Trust CO transactions in Castle Biosciences Inc stock. As of the latest transaction made, Coastline Trust CO holds 100 shares of CSTL stock, worth $3,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$3,217
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$17.4 - $31.47 $1,739 - $3,147
100 New
100 $2,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $846M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Coastline Trust CO Portfolio

Follow Coastline Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.